Pantheon Investment Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$1.16M Sell
15,160
-2,627
-15% -$209K 0.91% 45
2021
Q3
$1.35M Sell
17,787
-999
-5% -$76K 1.16% 32
2021
Q2
$1.46M Sell
18,786
-2,061
-10% -$153K 1.22% 31
2021
Q1
$1.53M Buy
20,847
+5,692
+38% +$420K 1.47% 25
2020
Q4
$1.18M Sell
15,155
-706
-4% -$54K 1.29% 31
2020
Q3
$1.26M Sell
15,861
-1,859
-10% -$146K 1.5% 25
2020
Q2
$1.31M Buy
17,720
+1,821
+11% +$137K 1.64% 21
2020
Q1
$1.17M Buy
15,899
+10,126
+175% +$796K 1.76% 22
2019
Q4
$502K Buy
+5,773
New +$474K 0.47% 54

Other funds holding MRK

Pantheon Investment Group's MRK Position: Q4 2021 in Review

Pantheon Investment Group reduced its Merck (MRK) stake by 15% in Q4 2021, selling an estimated $209K and leaving 15,160 shares worth $1.16M. The position accounts for 0.91% of the portfolio, ranked #45.

Pantheon Investment Group first reported a position in MRK in Q4 2019 and has held it in 9 quarters since. The position peaked at $1.53M in Q1 2021. 2,902 funds tracked by Wall St. Rank hold MRK as of Q4 2021.

  • Pantheon Investment Group held 15,160 shares of Merck worth $1.16M as of Q4 2021.
  • Pantheon Investment Group sold 2,627 Merck shares in Q4 2021, an estimated $209K.
  • Merck made up 0.91% of Pantheon Investment Group's portfolio in Q4 2021, its #45 holding.
  • Pantheon Investment Group first reported a position in Merck in Q4 2019 and has held it in 9 quarters since.
  • Pantheon Investment Group's Merck position peaked at $1.53M in Q1 2021.
  • 2,902 funds tracked by Wall St. Rank held Merck as of Q4 2021.

Based on Pantheon Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.